Periodic Reporting for period 1 - METHYLOMIC (DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.)

Monoclonal antibodies have revolutionized the treatment landscape for immune-mediated inflammatory diseases (IMIDs) such as Crohn’s disease (CD), rheumatoid arthritis (RA), and psoriasis (PsO). These biologic therapies, targeting key inflammatory pathways, offer hope to many...